Cargando…
Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls
The existence of repressive and durable chromatin assemblies along gene promoters or networks, especially in the brain, is of theoretical and therapeutic relevance in a subset of individuals diagnosed with schizophrenia who experience a chronic, persistent, and treatment-resistant trajectory. We use...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644155/ https://www.ncbi.nlm.nih.gov/pubmed/36386965 http://dx.doi.org/10.3389/fpsyt.2022.1006109 |
_version_ | 1784826680742772736 |
---|---|
author | Rizavi, Hooriyah S. Chase, Kayla A. Liu, Chunyu Gavin, Hannah Rosen, Cherise Xia, Cuihua Guidotti, Alessandro Sharma, Rajiv P. |
author_facet | Rizavi, Hooriyah S. Chase, Kayla A. Liu, Chunyu Gavin, Hannah Rosen, Cherise Xia, Cuihua Guidotti, Alessandro Sharma, Rajiv P. |
author_sort | Rizavi, Hooriyah S. |
collection | PubMed |
description | The existence of repressive and durable chromatin assemblies along gene promoters or networks, especially in the brain, is of theoretical and therapeutic relevance in a subset of individuals diagnosed with schizophrenia who experience a chronic, persistent, and treatment-resistant trajectory. We used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to generate an epigenomic map that includes differential sites occupied by di-methylated lysine 9 of histone 3 (H3K9me2), a repressive modification that is yet unexplored in human postmortem brain tissue. We have discovered over 150 significantly differential promoter sites in the postmortem prefrontal cortex tissue of individuals diagnosed with schizophrenia (n = 15) when compared to controls (n = 15). Potentially dysregulated gene categories include postsynaptic proteins, processing enzymes (for proproteins, lipids, and oxidative stress), cadherin family genes, the complement system, and peptide hormones. Ten genes with significantly increased or decreased H3K9me2 promoter occupation were selected through statistical analysis, function, or previous GWAS association, and Quantitative RT-PCR (qRT-PCR) was performed on an extended sample of postmortem brain tissue, adding an additional 17 controls, 7 individuals with schizophrenia, and 19 individuals with bipolar samples (n = 32 control, 22 schizophrenia, 19 bipolar). This approach revealed that mRNA expression levels correlated with chromatin modification levels in eight of 10 selected genes, and mRNA expression in the total sample could be predicted by the occupancy of H3K9me2. Utilization of this method and replication in a larger sample open a pathway to durable and restrictive epigenomic assemblies whose accumulation across the lifespan of individuals diagnosed with schizophrenia may explain treatment resistance, and advance therapeutic options. |
format | Online Article Text |
id | pubmed-9644155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96441552022-11-15 Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls Rizavi, Hooriyah S. Chase, Kayla A. Liu, Chunyu Gavin, Hannah Rosen, Cherise Xia, Cuihua Guidotti, Alessandro Sharma, Rajiv P. Front Psychiatry Psychiatry The existence of repressive and durable chromatin assemblies along gene promoters or networks, especially in the brain, is of theoretical and therapeutic relevance in a subset of individuals diagnosed with schizophrenia who experience a chronic, persistent, and treatment-resistant trajectory. We used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to generate an epigenomic map that includes differential sites occupied by di-methylated lysine 9 of histone 3 (H3K9me2), a repressive modification that is yet unexplored in human postmortem brain tissue. We have discovered over 150 significantly differential promoter sites in the postmortem prefrontal cortex tissue of individuals diagnosed with schizophrenia (n = 15) when compared to controls (n = 15). Potentially dysregulated gene categories include postsynaptic proteins, processing enzymes (for proproteins, lipids, and oxidative stress), cadherin family genes, the complement system, and peptide hormones. Ten genes with significantly increased or decreased H3K9me2 promoter occupation were selected through statistical analysis, function, or previous GWAS association, and Quantitative RT-PCR (qRT-PCR) was performed on an extended sample of postmortem brain tissue, adding an additional 17 controls, 7 individuals with schizophrenia, and 19 individuals with bipolar samples (n = 32 control, 22 schizophrenia, 19 bipolar). This approach revealed that mRNA expression levels correlated with chromatin modification levels in eight of 10 selected genes, and mRNA expression in the total sample could be predicted by the occupancy of H3K9me2. Utilization of this method and replication in a larger sample open a pathway to durable and restrictive epigenomic assemblies whose accumulation across the lifespan of individuals diagnosed with schizophrenia may explain treatment resistance, and advance therapeutic options. Frontiers Media S.A. 2022-10-26 /pmc/articles/PMC9644155/ /pubmed/36386965 http://dx.doi.org/10.3389/fpsyt.2022.1006109 Text en Copyright © 2022 Rizavi, Chase, Liu, Gavin, Rosen, Xia, Guidotti and Sharma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Rizavi, Hooriyah S. Chase, Kayla A. Liu, Chunyu Gavin, Hannah Rosen, Cherise Xia, Cuihua Guidotti, Alessandro Sharma, Rajiv P. Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title | Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title_full | Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title_fullStr | Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title_full_unstemmed | Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title_short | Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
title_sort | differential h3k9me2 heterochromatin levels and concordant mrna expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644155/ https://www.ncbi.nlm.nih.gov/pubmed/36386965 http://dx.doi.org/10.3389/fpsyt.2022.1006109 |
work_keys_str_mv | AT rizavihooriyahs differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT chasekaylaa differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT liuchunyu differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT gavinhannah differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT rosencherise differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT xiacuihua differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT guidottialessandro differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols AT sharmarajivp differentialh3k9me2heterochromatinlevelsandconcordantmrnaexpressioninpostmortembraintissueofindividualswithschizophreniabipolarandcontrols |